Styrian Vitamin D Hypertension Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Arterial HypertensionVitamin D Deficiency
Interventions
DIETARY_SUPPLEMENT

Vitamin D3

The treatment group receives 2,800 IU vitamin D3 per day as oily drops (Oleovit D3, producer: Fresenius Kabi Austria, A-8055 Graz) for 8 weeks

DIETARY_SUPPLEMENT

Placebo

Trial Locations (1)

8036

Medical University of Graz, Graz

All Listed Sponsors
lead

Medical University of Graz

OTHER

NCT02136771 - Styrian Vitamin D Hypertension Trial | Biotech Hunter | Biotech Hunter